Showing posts with label immunotherapy. Show all posts
Showing posts with label immunotherapy. Show all posts
Wednesday, April 11, 2012
Tuesday, December 20, 2011
Deploying Immunotherapeutic Drones for Cancer
Nearly six scores ago, a Westfield, Connecticut, based bone surgeon, William Coley, injected a mixture of dead Streptococcus pyrogens and dead Serratia marcescens bacteria (called Coley's vaccine or Coley's toxins) in patients' tumors and obtained a near-complete remission. Nearly a quarter century after his death, the powerful immune stimulant in Coley's vaccine was identified as tumor necrosis factor-alpha (TNF-α) in 1968. Today, there is a renewed interest in Coley's approach and the immunotherapeutic strategies to control cancer.
Labels:
cervarix,
drug development,
gardasil,
IL2,
immunotherapy,
interferon-a,
ipilimumab,
provenge,
sipuleucel-T,
yervoy
Subscribe to:
Posts (Atom)